Dr Reddy’s receives EIR for API manufacturing facility
Inspection concluded at its API manufacturing facility in Srikakulam, Andhra Pradesh
The United States Food and Drug Administration (USFDA) concluded its inspection of Dr Reddy’s Laboratories’ API manufacturing facility in Srikakulam, Andhra Pradesh.
Dr Reddy’s received an Establishment Inspection Report (EIR) and the USFDA classified the inspection as Voluntary Action Indicated (VAI).
- Advertisement -